ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Carline Thistle

Also known as: Silybum marianum, Milk Thistle, Holy Thistle, Silymarin

Overview

Milk thistle, scientifically known as *Silybum marianum*, is a herbal supplement derived from a plant rich in flavonolignans, primarily silymarin. It has been traditionally used for its potential liver-protective properties. The active compound, silymarin, is recognized for its antioxidant and anti-inflammatory effects. While it's primarily used in the treatment and prevention of liver diseases, such as hepatitis, cirrhosis, and liver damage caused by toxins, the evidence supporting these uses is mixed. Some studies indicate minimal to no significant benefits, while others suggest potential benefits but are limited by methodological issues. Milk thistle is available in various forms, including capsules, tablets, and extracts, with standardized extracts containing 70-80% silymarin being the most common. The bioavailability of silymarin can be relatively low, but certain formulations, like phosphatidylcholine complexes, can enhance its absorption.

Benefits

The primary purported benefit of milk thistle is its potential to improve liver health, particularly in individuals with chronic liver diseases. However, a systematic review found no significant reduction in mortality or improvements in liver histology among patients treated with milk thistle. A small, statistically significant reduction in alanine aminotransferase (ALT) levels was observed, but this was not considered clinically significant. Similarly, a meta-analysis showed high heterogeneity among studies and no consistent significant benefits on serum levels of ALT, AST, and GGT in patients with liver diseases. Some studies suggest antioxidant and anti-inflammatory effects, but these are not consistently supported by high-quality clinical trials. The benefits, if any, appear to be most relevant for patients with chronic liver disease, but the evidence is not strong enough to support a clear recommendation. Observed effect sizes are generally small and not clinically significant.

How it works

Silymarin, the active compound in milk thistle, is believed to exert its effects through antioxidant and anti-inflammatory pathways, potentially protecting liver cells from damage. It may interact with the liver's detoxification processes and influence the activity of certain enzymes. Silymarin interacts with various molecular targets, including enzymes involved in the metabolism of drugs and toxins. The bioavailability of silymarin is relatively low, which may affect its efficacy. However, specific formulations can enhance absorption. Overall, the exact mechanisms are still being researched, but the primary focus is on its ability to reduce oxidative stress and inflammation in the liver.

Side effects

Milk thistle is generally considered safe and well-tolerated, with adverse effects being rare and similar to those in placebo groups. Common side effects are not consistently reported across studies. Uncommon side effects (1-5%) may include gastrointestinal symptoms such as nausea and diarrhea, though these are not significantly different from placebo. No significant rare side effects have been consistently reported. There is no significant evidence of milk thistle affecting the activity of major drug-metabolizing enzymes (CYP1A2, CYP2C9, CYP2D6, CYP3A4/5). No contraindications are well-established, but caution is advised in patients with allergies to plants in the Asteraceae family. Pregnant or breastfeeding women should use it with caution due to limited data on its safety in these populations.

Dosage

The minimum effective dose of milk thistle is not well-established, but typical dosages range from 200-400 mg of silymarin per day. Optimal dosages are not clearly defined, but doses up to 600 mg per day have been used in clinical trials. There is no established maximum safe dose, but doses above 600 mg per day are not commonly studied. No specific timing recommendations are available; it can be taken at any time of day. Standardized extracts containing 70-80% silymarin are commonly used. Bioavailability can be enhanced with certain formulations, such as phosphatidylcholine complexes. No specific cofactors are required for its use.

FAQs

Is milk thistle safe to use?

Milk thistle is generally safe but should be used under medical supervision, especially for patients with chronic liver disease. It is well-tolerated, but rare side effects can occur.

When is the best time to take milk thistle?

No specific timing is recommended; it can be taken at any time of day. Consistency is more important than timing.

What are the expected results from taking milk thistle?

There is limited evidence to support significant clinical benefits. It is often misconceived as a cure for liver diseases, but the evidence does not support this claim.

Can milk thistle interact with other medications?

There is no significant evidence of milk thistle affecting the activity of major drug-metabolizing enzymes, but it's always best to consult with a healthcare provider.

Who should avoid taking milk thistle?

Patients with allergies to plants in the Asteraceae family should use caution. Pregnant or breastfeeding women should also use it with caution due to limited data.

Research Sources

  • https://pubmed.ncbi.nlm.nih.gov/12427501/ – This systematic review of 14 trials involving 433 participants found that milk thistle did not significantly reduce mortality or improve liver histology in patients with chronic liver disease. While a small reduction in ALT levels was observed, it was not clinically significant. The review was limited by the quality of the included studies and high heterogeneity among them.
  • https://www.wjgnet.com/1007-9327/full/v23/i27/5004.htm – This meta-analysis evaluating the effect of silymarin on serum levels of ALT, AST, and GGT in patients with liver diseases showed high heterogeneity among studies and no consistent significant benefits. The methodological quality of the included studies was low, and there was a high risk of bias, limiting the reliability of the findings.
  • https://www.science.gov/topicpages/t/thistle+carduus+pycnocephalus.html – This URL provides general information about thistles, including Carduus pycnocephalus, but does not directly relate to the clinical efficacy or mechanisms of milk thistle (Silybum marianum). It is relevant for botanical context but not for specific research findings on milk thistle's effects.
  • https://uthscsa-staging.elsevierpure.com/en/publications/milk-thistle-for-the-treatment-of-liver-disease-a-systematic-revi – This systematic review assesses the efficacy of milk thistle for treating liver disease. It analyzes multiple trials and concludes that there is limited evidence to support its use in reducing mortality or improving liver histology, highlighting the need for further high-quality research to determine its true effectiveness.